OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
Sílvia Marcé, Aleix Méndez López, Blanca Xicoy, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 779-779
Open Access | Times Cited: 3
Sílvia Marcé, Aleix Méndez López, Blanca Xicoy, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 779-779
Open Access | Times Cited: 3
Showing 3 citing articles:
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study
Simona Bernardi, Alessia Cavalleri, Silvia Mutti, et al.
Annals of Hematology (2024)
Open Access | Times Cited: 4
Simona Bernardi, Alessia Cavalleri, Silvia Mutti, et al.
Annals of Hematology (2024)
Open Access | Times Cited: 4
The PD1 Molecule May Contribute to Lower Treatment-Free Remission Rates in Patients with Chronic Myeloid Leukemia with the e13a2 Transcript
Paulina Kwaśnik, Michał Kiełbus, Joanna Zaleska, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2304-2304
Open Access
Paulina Kwaśnik, Michał Kiełbus, Joanna Zaleska, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2304-2304
Open Access
Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice
Aamer Aleem, Naila Shaheen, Farjah Algahtani, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Aamer Aleem, Naila Shaheen, Farjah Algahtani, et al.
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
